Morning Market Gainers

shares jumped 23.07 percent to $2.76 following announcement of positive Phase 3 study CPX-351 results in patients with high-risk acute Myeloid Leukemia.

climbed 22.22 percent to $1.76 after the company lifted its Q2 sales forecast.

gained 8.77 percent to $19.09 following announcement of partnership with

on cloud.

shares rose 6.60 percent to $13.40. Nektar Therapeutics will replace

in the S&P SmallCap 600 after the close of trading on June 25.

shares gained 5.03 percent to $4.19 after the company reported encouraging top-line results in proof-of-concept trial of vigabatrin in patients with Treatment-Refractory Tourette's Disorder. MLV & Co. initiated coverage on Catalyst Pharmaceuticals with a Buy rating and a $14.00 price target.

rose 5.43 percent to $51.66 after the company reported stronger-than-expected results for its fiscal second quarter.

shares surged 3.18 percent to $64.71 after dropping 1.75 percent on Tuesday.

shares gained 2.06 percent to $695.20 after the company announced a 7-for-1 stock split. The split will take the form of a stock dividend payable on July 14 to holders of record at the close of business on July 2. Netflix will begin trading at the post-split price on July 15.